Jonah Campbell
Datos Biográficos
| ID | 3581584 |
|---|---|
| NOMBRE | Jonah Campbell |
| NOMBRES | Jonah |
| APELLIDO | Campbell |
| FIRMA | CAMPBELL J |
| AFILIACIONES | McGill University |
| ORCID | 0000-0003-2480-8912 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAS | 12 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2017 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 2 |
Histology agnosticism
The term "molecularization" has been used by historians and sociologists of science to describe the transition from an anatomic view of the body to a submicroscopic one, where health and illness, indeed life itself, are increasingly defined in terms of an individual's "genetic landscape." Here we introduce the notion of the infra-molecular as a way of extending and nuancing the molecularization trope as it applies to the domain of (post)genomic o…
Decision‐making as discovery
Based on fieldwork carried out at the Early Drug Development Service of a world‐leading cancer institution, our study sheds lights on decision‐making processes at the stage where decisions are made about which clinical trial to pursue and thus which experimental drugs will feed the growing pipeline of molecularly guided therapies and therapeutic strategies available to treating physicians. The paper shows how such collective decision‐making pract…
Organizing precision medicine
Multi-polar scripts
Healthcare policy by other means
Beyond nosology? Molecular tumor boards, singularization, and the conflation of diagnosis and therapy
This article partakes in a number of recent attempts to map the reconfiguration of clinical work as part of the deployment of precision oncology. We focus on the platforms, in particular Molecular Tumor Boards, that act as a condition of possibility for implementing innovative experimental interventions, and which are part of the emergence, beyond the traditional confines of diagnosis, of a data “ecosystem” geared towards increasing patient acces…
Unsettling circularity”
The US Food and Drug Administration’s approval of the controversial analgesic Zohydro has drawn attention to its endorsement of so-called ‘enrichment strategies’ for streamlining clinical trials. Among these is ‘enriched enrollment randomized withdrawal’ (EERW), a design intended to improve measures of drug efficacy by screening out patients who are non-responsive or suffer adverse effects. EERW has been promoted as a response to the problem of h…
Organizing precision medicine
Multi-polar scripts
Decision‐making as discovery
Based on fieldwork carried out at the Early Drug Development Service of a world‐leading cancer institution, our study sheds lights on decision‐making processes at the stage where decisions are made about which clinical trial to pursue and thus which experimental drugs will feed the growing pipeline of molecularly guided therapies and therapeutic strategies available to treating physicians. The paper shows how such collective decision‐making pract…
Histology agnosticism
The term "molecularization" has been used by historians and sociologists of science to describe the transition from an anatomic view of the body to a submicroscopic one, where health and illness, indeed life itself, are increasingly defined in terms of an individual's "genetic landscape." Here we introduce the notion of the infra-molecular as a way of extending and nuancing the molecularization trope as it applies to the domain of (post)genomic o…
Healthcare policy by other means
Unsettling circularity”
The US Food and Drug Administration’s approval of the controversial analgesic Zohydro has drawn attention to its endorsement of so-called ‘enrichment strategies’ for streamlining clinical trials. Among these is ‘enriched enrollment randomized withdrawal’ (EERW), a design intended to improve measures of drug efficacy by screening out patients who are non-responsive or suffer adverse effects. EERW has been promoted as a response to the problem of h…
Beyond nosology? Molecular tumor boards, singularization, and the conflation of diagnosis and therapy
This article partakes in a number of recent attempts to map the reconfiguration of clinical work as part of the deployment of precision oncology. We focus on the platforms, in particular Molecular Tumor Boards, that act as a condition of possibility for implementing innovative experimental interventions, and which are part of the emergence, beyond the traditional confines of diagnosis, of a data “ecosystem” geared towards increasing patient acces…
Multi-polar scripts
Healthcare policy by other means
Decision‐making as discovery
Based on fieldwork carried out at the Early Drug Development Service of a world‐leading cancer institution, our study sheds lights on decision‐making processes at the stage where decisions are made about which clinical trial to pursue and thus which experimental drugs will feed the growing pipeline of molecularly guided therapies and therapeutic strategies available to treating physicians. The paper shows how such collective decision‐making pract…
Organizing precision medicine
Histology agnosticism
The term "molecularization" has been used by historians and sociologists of science to describe the transition from an anatomic view of the body to a submicroscopic one, where health and illness, indeed life itself, are increasingly defined in terms of an individual's "genetic landscape." Here we introduce the notion of the infra-molecular as a way of extending and nuancing the molecularization trope as it applies to the domain of (post)genomic o…
Medicine (6 obras) · Pathology (4 obras) · Cancer Genomics and Diagnostics (3 obras) · Clinical trial (3 obras) · Computer Science (3 obras) · Engineering (3 obras) · Engineering ethics (3 obras) · Psychology (3 obras) · Biomedical and Engineering Education (2 obras) · Biomedical Ethics and Regulation (2 obras)